United Kingdom

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

19 Jul 2019
Change (% chg)

¥84 (+1.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Ohwa, Takashi 

Mr. Takashi Ohwa has been serving as Executive Officer, Chief Medicine Creation Officer of Oncology Business Group and Chief Discovery Officer of Oncology Business Group in Eisai Co., Ltd. since April 2016. He joined the Company in April 1991. His previous titles include Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --